We are live on
!
Find out more
Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$116B
1-Year Est. Return
26.37%
This Fund
S&P 500
This Quarter
Est. Return
+0.78%
1 Year Est. Return
+26.37%
3 Year Est. Return
+67.38%
5 Year Est. Return
+85.79%
10 Year Est. Return
+313.78%
AUM
$122B
AUM Growth
-$1.01B
(-0.82%)
Cap. Flow
-$2.02B
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
17.57%
Holding
3,327
New
114
Increased
1,021
Reduced
1,901
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AB InBev
BUD
|
+$294M |
| 2 |
Intuitive Surgical
ISRG
|
+$185M |
| 3 |
Royal Bank of Canada
RY
|
+$179M |
| 4 |
Lennar Class A
LEN
|
+$147M |
| 5 |
NVIDIA
NVDA
|
+$145M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$570M |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$396M |
| 3 |
Telus
TU
|
+$367M |
| 4 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$262M |
| 5 |
John Hancock Multifactor Developed International ETF
JHMD
|
+$229M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.35% |
| 2 | Technology | 15.23% |
| 3 | Healthcare | 10.98% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
MediaAlpha
MAX
$814M
| $201K | ﹤0.01% |
10,783
-439
| -4% | -$11.9K |
|
2977
Spyre Therapeutics
SYRE
$8.98B
| $201K | ﹤0.01% |
1,013
-48
| -5% | -$8.39K |
|
2978
NVE Corp
NVEC
$562M
| $200K | ﹤0.01% |
3,122
-231
| -7% | -$16.4K |
|
2979
Occidental Petroleum Corp Warrants
OXY.WS
$33.6B
| $200K | ﹤0.01% |
16,857
| – | – |
|
|
EGIO
2980
DELISTED
Edgio, Inc. Common Stock
EGIO
| $200K | ﹤0.01% |
2,099
+164
| +8% | +$17.3K |
|
2981
Full House Resorts
FLL
$85M
| $199K | ﹤0.01% |
18,775
-1,068
| -5% | -$9.12K |
|
2982
Arbutus Biopharma
ABUS
$896M
| $198K | ﹤0.01% |
46,204
-2,661
| -5% | -$8.87K |
|
2983
Pure Cycle
PCYO
$273M
| $198K | ﹤0.01% |
14,852
-1,222
| -8% | -$17.7K |
|
2984
AXT Inc
AXTI
$5.07B
| $197K | ﹤0.01% |
23,651
-586
| -2% | -$5.46K |
|
2985
Latham Group
SWIM
$896M
| $197K | ﹤0.01% |
12,004
-100,675
| -89% | -$2.35M |
|
2986
Tilly's
TLYS
$123M
| $197K | ﹤0.01% |
14,076
-656
| -4% | -$9.96K |
|
|
KALV
2987
DELISTED
KalVista Pharmaceuticals
KALV
| $196K | ﹤0.01% |
11,247
-474
| -4% | -$9.61K |
|
2988
Alto Ingredients
ALTO
$326M
| $194K | ﹤0.01% |
39,320
-1,429
| -4% | -$7.2K |
|
2989
Babcock & Wilcox
BW
$1.4B
| $194K | ﹤0.01% |
30,207
-969
| -3% | -$6.76K |
|
2990
CytomX Therapeutics
CTMX
$736M
| $194K | ﹤0.01% |
38,032
-1,249
| -3% | -$6.69K |
|
2991
Microvast
MVST
$344M
| $194K | ﹤0.01% |
+23,653
| New | +$248K |
|
2992
Instil Bio
TIL
$49.7M
| $193K | ﹤0.01% |
539
-24
| -4% | -$8.96K |
|
2993
Riverview Bancorp
RVSB
$107M
| $192K | ﹤0.01% |
26,448
| – | – |
|
2994
BeyondSpring
BYSI
$41M
| $191K | ﹤0.01% |
12,093
-3,761
| -24% | -$67.6K |
|
|
SQZ
2995
DELISTED
SQZ Biotechnologies Company
SQZ
| $191K | ﹤0.01% |
13,240
-667
| -5% | -$9.04K |
|
2996
Aligos Therapeutics
ALGS
$42.3M
| $190K | ﹤0.01% |
491
+48
| +11% | +$19K |
|
|
BZUN
2997
Baozun
BZUN
$167M
| $189K | ﹤0.01% |
10,800
+600
| +6% | +$14.8K |
|
2998
Lineage Cell Therapeutics
LCTX
$268M
| $189K | ﹤0.01% |
74,991
-3,053
| -4% | -$7.83K |
|
|
LONA
2999
LeonaBio Inc
LONA
$73.9M
| $188K | ﹤0.01% |
2,001
+95
| +5% | +$9.67K |
|
3000
Lexicon Pharmaceuticals
LXRX
$1.04B
| $188K | ﹤0.01% |
39,070
-2,455
| -6% | -$10.1K |
|
Similar funds
VAM
Manulife (Manufacturers Life Insurance)'s Q3 2021 Portfolio in Review
As of Q3 2021, Manulife (Manufacturers Life Insurance) held 3,327 positions worth $122B, down 0.82% from $123B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Manulife (Manufacturers Life Insurance)'s Q3 2021 filing shows 114 new, 1,021 increased, 1,901 reduced and 189 closed positions. Its largest new stake was iShares US Healthcare ETF: 1,636,635 shares worth $90.3M. The largest sale was Bank of America, an estimated $570M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
- Manulife (Manufacturers Life Insurance)'s largest Q3 2021 buy was iShares US Healthcare ETF: 1,636,635 shares worth $90.3M.
- Manulife (Manufacturers Life Insurance) added most to AB InBev in Q3 2021, an estimated $294M increase.
- Manulife (Manufacturers Life Insurance)'s biggest Q3 2021 reduction was Bank of America, cutting an estimated $570M.
- Manulife (Manufacturers Life Insurance) fully exited Brookfield Property Partners L.P. Limited Partnership Units in Q3 2021, selling an estimated $262M.
- Manulife (Manufacturers Life Insurance)'s ten largest holdings make up 18% of its $122B portfolio in Q3 2021.
- Manulife (Manufacturers Life Insurance) opened 114 new positions and closed 189 in Q3 2021.
- Manulife (Manufacturers Life Insurance)'s portfolio value fell 0.82% quarter-over-quarter to $122B.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2021, filed 12 Nov 2021.